Akari Therapeutics (AKTX) 6-K This Document Is Important and Requires Your Immediate Attention

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

June 2020

Commission file number: 001-36288

Akari Therapeutics, Plc

(Translation of registrant's name into English)

75/76 Wimpole Street

London W1G 9RT

United Kingdom

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  x       Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1):                      

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7):                      

CONTENTS

On June 1, 2020, Akari Therapeutics, Plc (the “Company”) announced that it will hold its Annual General Meeting of Shareholders on June 30, 2020. In connection with the meeting, the Company furnished the following documents:

1. Notice and Proxy Statement to Shareholders dated June 1, 2020

2. Form of Proxy Card

3. Statutory Accounts for the year ended December 31, 2019

The information contained in this report (including the exhibits hereto) is hereby incorporated by reference into all effective registration statements filed by the Company under the Securities Act of 1933.

Exhibit No.

99.1 Notice of Annual General Meeting of Shareholders and Proxy Statement

99.2 Form of Proxy Card

99.3 Statutory Accounts for the year ended December 31, 2019

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Akari Therapeutics, Plc
(Registrant)
By:	/s/ Clive Richardson
Name:	Clive Richardson
	Chief Executive Officer and Chief Operating Officer

Date: June 1, 2020